Probing Integrin Selectivity: Rational Design of Highly Active and Selective Ligands for the α5β1 and αvβ3 Integrin Receptor
- 27 April 2007
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 46 (19) , 3571-3574
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Design, Synthesis, and Biological Evaluation of Novel Potent and Selective αvβ3/αvβ5 Integrin Dual Inhibitors with Improved Bioavailability. Selection of the Molecular CoreJournal of Medicinal Chemistry, 2005
- Nonpeptide αvβ3 Antagonists. 8. In Vitro and in Vivo Evaluation of a Potent αvβ3 Antagonist for the Prevention and Treatment of OsteoporosisJournal of Medicinal Chemistry, 2003
- Therapeutic antagonists and conformational regulation of integrin functionNature Reviews Drug Discovery, 2003
- IntegrinsCell, 2002
- Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp LigandScience, 2002
- Bibliotheken niedermolekularerαvβ3-Integrinantagonisten: On-Bead-Screening und massenspektrometrische Identifizierung ohne CodierungAngewandte Chemie, 2001
- N-Methylated Cyclic RGD Peptides as Highly Active and Selective αVβ3Integrin AntagonistsJournal of Medicinal Chemistry, 1999
- Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv IntegrinsCell, 1998
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Arg‐Gly‐Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1FEBS Letters, 1991